U.S. Food and Drug Administration
U.S. Food and Drug Administration Articles
There is an old rule of thumb from biotech investors and traders… SELL FDA APPROVALS. This is very counter-intuitive on the surface but we wanted to explain in more detail why this is the case...
Published:
Last Updated:
If you have seen the graphic images that will go on cigarette packages late in 2011, you might think that the tobacco companies have finally met their match. The graphic images are intended to...
Published:
Last Updated:
If Altria Group Inc. (NYSE: MO), Reynolds American Inc. (NYSE: RAI), Anheuser-Busch InBev (NYSE: BUD), and Molson Coors Brewing Company (NYSE: TAP) should keep an eye on efforts to legalize...
Published:
Last Updated:
The FDA is about to give some serious warning labels on cigarette labels. Altria Group Inc. (NYSE: MO), Reynolds American Inc. (NYSE: RAI), Lorillard, Inc. (NYSE: LO) and Vector Group Ltd. (NYSE:...
Published:
Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011. Its share volume has increased on all but one of the last six...
Published:
This last week marked another solid week for investors and many stocks were on the move. We have compiled a list of stocks we are looking for event-driven trading moves in the coming week that are...
Published:
Last Updated:
When we first covered K-V Pharmaceutical Co. (NYSE: KV-A) for its Makena drug market exclusivity to prevent premature birth, we knew this was going to be a home run. But earlier in March when it...
Published:
Last Updated:
The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma. The approval is a win for Bristol-Myers...
Published:
Last Updated:
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the ten-baggers that were seen in 2009. In 2009, companies like Jazz Pharmaceuticals, Inc....
Published:
Last Updated:
The world of biotech and biohealth is seeing a flurry of news today. This is bringing on many winners and losers in the sector. We are tracking the news and the moves in Alexza Pharmaceuticals...
Published:
Last Updated:
Stem cell stocks are getting hit pretty hard this Tuesday. On Monday came a ruling from a U.S. district judge which effectively blocks the federal government from funding research which involves...
Published:
Last Updated:
There are many issues to watch in the coming week for this weekend’s edition of THE UNUSUAL SUSPECTS. We have some earnings on deck and some unfinished business from last week, but there are...
Published:
Last Updated:
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are...
Published:
Last Updated:
There were many stocks in Biotech and BioHealth with plus-signs after their share prices today. The BioHealth Business Daily is smoothing out the brief winners and losers to only weed out the...
Published:
Last Updated: